- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05860959
SUBLOCADE Resultaten op lange termijn
Een fase IV longitudinaal onderzoek naar de klinische resultaten van SUBLOCADE (SUBUTEX verlengde afgifte) bij volwassenen met opioïdengebruiksstoornis (opioïdenafhankelijkheid)
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
This is a Phase IV, prospective, multicentre, multinational, open-label, real-world observational study in participants with current or a history of OUD/opioid dependence.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
-
Richmond, Australië, VIC 3121
- Turning Point
-
-
Melbourne
-
Fitzroy, Melbourne, Australië, 3065
- St Vincent's Hospital Melbourne
-
-
New South Wales
-
Newcastle, New South Wales, Australië, 2300
- John Hunter Hospital
-
-
South Australia
-
Stepney, South Australia, Australië, 5069
- Drug and Alcohol Services South Australia (DASSA)
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2E2R2
- Smart Clinic
-
Edmonton, Alberta, Canada, T5J 3E4
- Recovery Alberta
-
-
British Columbia
-
Surrey, British Columbia, Canada, V3T 0H1
- Fraser Health Authority
-
-
Ontario
-
Burlington, Ontario, Canada, L7M 4X9
- Dr. J.S. Dhillon Medicine Prof. Corp
-
Hamilton, Ontario, Canada, L8N 1H3
- The Stipley Clinic
-
Owen Sound, Ontario, Canada, N4K 6M9
- Brightshores Health System
-
Sarnia, Ontario, Canada, N7T 5W9
- Bluewater Rapid Assessment Addiction Medicine Clinic
-
Toronto, Ontario, Canada, M4J 1M3
- Comprehensive Treatment Clinic
-
-
-
-
California
-
Costa Mesa, California, Verenigde Staten, 92626
- ATP Clinical Research
-
Escondido, California, Verenigde Staten, 92025
- Neighborhood Healthcare-Institute of Health
-
-
Connecticut
-
Westport, Connecticut, Verenigde Staten, 06880
- Elevate Health and Wellness
-
-
Florida
-
Hialeah, Florida, Verenigde Staten, 33012
- United Research Institute
-
Hollywood, Florida, Verenigde Staten, 33021
- Zenith Clinical Research LLC
-
Miami, Florida, Verenigde Staten, 33126
- Jackson Health Community Center
-
Miami, Florida, Verenigde Staten, 33134
- G+C Research Group
-
-
Georgia
-
Decatur, Georgia, Verenigde Staten, 30033-4004
- Atlanta VA Medical Center
-
-
Kansas
-
Kansas City, Kansas, Verenigde Staten, 66160
- University of Kansas Medical Center
-
Prairie Village, Kansas, Verenigde Staten, 66210
- Collective Medical Research.
-
-
Maine
-
Scarborough, Maine, Verenigde Staten, 04074-7163
- Maine Health
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21229
- Maryland Treatment Centers
-
-
Massachusetts
-
Springfield, Massachusetts, Verenigde Staten, 01199
- Baystate Health
-
-
Michigan
-
Dearborn, Michigan, Verenigde Staten, 48124
- THRYV Clinical Studies
-
Dearborn Heights, Michigan, Verenigde Staten, 48127
- Vida Clinical Studies
-
Detroit, Michigan, Verenigde Staten, 48201
- Wayne State University Hospital
-
Fair Haven, Michigan, Verenigde Staten, 48023
- North Point Medical Center
-
Grand Rapids, Michigan, Verenigde Staten, 49503-4224
- SHMG Center for Integrative Medicine
-
-
Mississippi
-
Tupelo, Mississippi, Verenigde Staten, 38801
- North Mississippi Medical Center
-
-
Missouri
-
St Louis, Missouri, Verenigde Staten, 63141-8704
- Psych Care Consultants
-
-
New York
-
Amherst, New York, Verenigde Staten, 14226
- DENT Neurologic Institute
-
Binghamton, New York, Verenigde Staten, 13903
- United Health Services
-
New York, New York, Verenigde Staten, 10029
- Icahn School of Medicine at Mount Sinai
-
North New Hyde Park, New York, Verenigde Staten, 11042
- Core Clinical Trials
-
Rockville Centre, New York, Verenigde Staten, 11570
- Stuart Wasser Practice
-
-
North Carolina
-
Charlotte, North Carolina, Verenigde Staten, 28277
- Onsite Clinical Solutions LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Verenigde Staten, 73112
- Pahl Pharmaceutical Professionals LLC
-
-
Oregon
-
Corvallis, Oregon, Verenigde Staten, 97330
- Healing Comfort Clinic, LLC
-
-
Pennsylvania
-
Narberth, Pennsylvania, Verenigde Staten, 19072
- Thalia Medical Centre
-
-
South Carolina
-
Charleston, South Carolina, Verenigde Staten, 29407
- Charleston Pain and Rehabilitation Center
-
Columbia, South Carolina, Verenigde Staten, 29205
- Midlands Neurology
-
Greenville, South Carolina, Verenigde Staten, 29605
- Prisma Health
-
-
Texas
-
Houston, Texas, Verenigde Staten, 77043
- Biopharma Informatic, Inc. Research Center
-
-
Utah
-
Clinton, Utah, Verenigde Staten, 84015
- Alpine Research Organization
-
-
Virginia
-
Richmond, Virginia, Verenigde Staten, 23219
- Virginia Commonwealth University
-
-
-
-
-
Linköping, Zweden, 58185
- Linkoping University Hospital, Psychiatry Center
-
Stockholm, Zweden, SE-11365
- Beroendecentrum
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Participants may enroll if they have initiated treatment with SUBLOCADE within 3 months prior to signing the informed consent form (ICF), or have completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and received their last dose of SUBLOCADE on the study within 3 months prior to signing the ICF, and plan to receive additional SUBLOCADE injections.
Beschrijving
Inclusion Criteria:
Participants must meet all of the following criteria:
-
Is an adult ≥ 18 years of age who has signed the informed consent form
-
Plans to receive additional SUBLOCADE injections and
-
Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
- OR
-
Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
-
-
Is not currently participating in any clinical trial requiring medical intervention
-
Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Participants achieving DSM-5 remission, early or sustained, (yes/no) while on initial SUBLOCADE treatment by 6 months and 1, 1.5, 2, 2.5, and 3 years from study Baseline
Tijdsspanne: up to a maximum of 4 years
|
|
up to a maximum of 4 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Key Secondary: Participants with "no symptoms" or improving by ≥1 DSM-5 severity classification within the last 3 months (moderate to mild, or severe to mild or moderate) relative to study Baseline (yes/no) at Month 6 and Years 1, 2, and 3
Tijdsspanne: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Among those starting SUBLOCADE within 3 months of study Baseline, time to achieve early remission for the first time while on initial SUBLOCADE treatment
Tijdsspanne: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Participants achieving DSM-5 sustained remission (yes/no) by 1, 1.5, 2, 2.5, and 3 years while on initial SUBLOCADE treatment
Tijdsspanne: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Time to achieve sustained remission for the first time while on initial SUBLOCADE treatment
Tijdsspanne: up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Time to discontinuing initial SUBLOCADE treatment and the corresponding reasons for discontinuation, eg, resolution of OUD symptoms, safety concerns, treatment failure, or seeking alternative MOUD treatment
Tijdsspanne: up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
Participants switching from initial SUBLOCADE treatment to another MOUD (yes/no), and the corresponding reasons, eg, safety concerns, treatment failure, seeking alternative MOUD treatment
Tijdsspanne: up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
The overall treatment duration for participants who stop initial SUBLOCADE treatment as the result of resolution of OUD symptoms
Tijdsspanne: up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
Participants with any positive opioid use in the past month (yes/no) at Month 6 and Years 1, 2, and 3 while on initial SUBLOCADE treatment
Tijdsspanne: up to a maximum of 4 years
|
Illicit Opioid Use (Self-Reports) |
up to a maximum of 4 years
|
|
Participants with opioid overdose requiring intervention (yes/no) while on initial SUBLOCADE treatment at least once during the first 6 months, and during Years 1, 2, and 3
Tijdsspanne: up to a maximum of 4 years
|
Opioid Overdose Requiring Intervention |
up to a maximum of 4 years
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- INDV-6000-406
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .